Gene Therapy for Hemophilia copertina

Gene Therapy for Hemophilia

Gene Therapy for Hemophilia

Di: Canadian Hemophilia Society
Ascolta gratuitamente

A proposito di questo titolo

Gene therapy has remained a constant prospect in the sphere of hemophilia treatment. For over two decades and the question remained: Is this just a dream, or could it one day become a reality?

Hemophilia gene therapy has finally been approved.

David Page talks to hemophilia specialists that will dive deep into understanding how the treatment works, its significance in advancing treatment, and how a one time treatment could change a severe condition to a milder one.Though not a definitive cure, gene therapy for hemophilia has transformed the dream of a cure into a reality for the future.

David and his guests will provide exclusive insights into one of the most significant medical breakthroughs of our era.

© 2023-2026 Disturbo fisico e malattia Igiene e vita sana Medicina alternativa e complementare
Episodi
  • Shared Decision-Making

    Shared Decision-Making
    Feb 11 2026

    Over the last several years, gene therapy for hemophilia B has become a reality. Some received it through clinical trials, and others received it after marketing authorizations and reimbursement approvals in their countries. Each of them had a difficult, life-changing decision to make. They needed to fully understand the potential benefits and risks, and the physicians responsible for their treatment needed to be assured that they were providing fully informed consent to the therapy. This process is called shared decision-making. In this episode of our second podcast series, GENE THERAPY FOR HEMOPHILIA – FROM DREAM TO REALITY, four people, two physicians and two people with hemophilia, were invited to share their insight on this topic.

    Host: Sarah Ford, CEO, Canadian Hemophilia Society

    Guest Speakers: Dr Pratima Chowdary, U.K.; Dr Davide Matino, Canada; Brian O'Mahony, Ireland; David Page, Canada

    This series is a creation of The Canadian Hemophilia Society - to find out more go to www.hemophilia.ca/gene-therapy

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    Mostra di più Mostra meno
    28 min
  • Four People Describe Their Experiences with Hemophilia B Gene Therapy

    Four People Describe Their Experiences with Hemophilia B Gene Therapy
    Feb 11 2026

    Over the last several years, gene therapy for hemophilia B has become a reality. Some received it through clinical trials. Others received it after marketing authorizations and reimbursement approvals in their countries. In this episode of our second podcast series, GENE THERAPY FOR HEMOPHILIA – FROM DREAM TO REALITY, four of these people were asked “Are you happy you made the decision to receive gene therapy? Why or why not?”

    Host: David Page, Canadian Hemophilia Society

    Guest Speakers: Daan Breederveld, Netherlands; Stephen Brown, Canada, John Curley, U.K.; Brian O'Mahony, Ireland

    This series is a creation of The Canadian Hemophilia Society - to find out more go to www.hemophilia.ca/gene-therapy

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    Mostra di più Mostra meno
    35 min
  • If Gene Therapy for Hemophilia B Were Available Tomorrow, Would You Want to Receive It?

    If Gene Therapy for Hemophilia B Were Available Tomorrow, Would You Want to Receive It?
    Jan 28 2026

    For the last 40 years, we have witnessed tremendous advances in care and treatment for people with hemophilia. Gene therapy has been a dream for most of those 40 years, and the last two to three years, two gene therapies for hemophilia B have been approved by regulatory bodies. But are they for everybody? In this episode of our second podcast series, GENE THERAPY FOR HEMOPHILIA – FROM DREAM TO REALITY, we will ask four people with severe hemophilia B to answer this question, “If gene therapy for hemophilia B were available tomorrow, where you live, would you want to receive it?”

    Host: Brian O’Mahony, Chief Executive, Irish Haemophilia Society

    Guest Speakers: James Foley, Ireland; Brian O'Loughlin, Ireland; David Page, Canada; Joseph Walsh, Ireland

    This series is a creation of The Canadian Hemophilia Society - to find out more go to www.hemophilia.ca/gene-therapy

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    Mostra di più Mostra meno
    24 min
Ancora nessuna recensione